101 results
Page 2 of 6
8-K
EX-99.2
4ij6j72btckapt0nxsv
17 Oct 22
Results support potential clinically meaningful activity of fosgonimeton without background therapy and mitigate program risk
8:30am
8-K
EX-99.2
4g7132d9
22 Jun 22
Athira Pharma Announces Topline Results from ACT-AD Phase 2 Proof of Concept Study of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease
7:05am
DFAN14A
EX-99.1
58yk40wrh7 0pvj5
27 Apr 22
Additional proxy materials by non-management
2:39pm
DEFA14A
sbms l6t6
26 Apr 22
Additional proxy soliciting materials
8:17am
DEFA14A
utcnb fcd3mgzlq
26 Apr 22
Additional proxy soliciting materials
8:11am
DFAN14A
EX-99.1
ieandbs7cs9wleuz7vw
25 Apr 22
Additional proxy materials by non-management
3:31pm
DEFA14A
7gbwf w69i6t59g
11 Apr 22
Additional proxy soliciting materials
4:36pm
DFAN14A
vr5fr6bl
11 Apr 22
Additional proxy materials by non-management
8:53am
DEFC14A
3lf2y
11 Apr 22
Proxy in contested solicitation
8:36am